1. Home
  2. NVAX vs AAT Comparison

NVAX vs AAT Comparison

Compare NVAX & AAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • AAT
  • Stock Information
  • Founded
  • NVAX 1987
  • AAT 1967
  • Country
  • NVAX United States
  • AAT United States
  • Employees
  • NVAX N/A
  • AAT N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • AAT Real Estate Investment Trusts
  • Sector
  • NVAX Health Care
  • AAT Real Estate
  • Exchange
  • NVAX Nasdaq
  • AAT Nasdaq
  • Market Cap
  • NVAX 1.3B
  • AAT 1.2B
  • IPO Year
  • NVAX 1995
  • AAT 2011
  • Fundamental
  • Price
  • NVAX $6.00
  • AAT $19.05
  • Analyst Decision
  • NVAX Buy
  • AAT Hold
  • Analyst Count
  • NVAX 6
  • AAT 2
  • Target Price
  • NVAX $17.83
  • AAT $23.00
  • AVG Volume (30 Days)
  • NVAX 6.0M
  • AAT 514.4K
  • Earning Date
  • NVAX 05-09-2025
  • AAT 04-29-2025
  • Dividend Yield
  • NVAX N/A
  • AAT 7.14%
  • EPS Growth
  • NVAX N/A
  • AAT 12.42
  • EPS
  • NVAX N/A
  • AAT 0.94
  • Revenue
  • NVAX $682,162,000.00
  • AAT $453,339,000.00
  • Revenue This Year
  • NVAX $1.07
  • AAT $4.44
  • Revenue Next Year
  • NVAX N/A
  • AAT $1.87
  • P/E Ratio
  • NVAX N/A
  • AAT $20.24
  • Revenue Growth
  • NVAX N/A
  • AAT 3.79
  • 52 Week Low
  • NVAX $3.81
  • AAT $16.69
  • 52 Week High
  • NVAX $23.86
  • AAT $29.15
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 41.41
  • AAT 44.61
  • Support Level
  • NVAX $5.01
  • AAT $18.75
  • Resistance Level
  • NVAX $6.58
  • AAT $18.65
  • Average True Range (ATR)
  • NVAX 0.65
  • AAT 0.80
  • MACD
  • NVAX 0.02
  • AAT 0.10
  • Stochastic Oscillator
  • NVAX 50.25
  • AAT 62.77

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

Share on Social Networks: